Oxeia Biopharmaceuticals
Oxeia Biopharmaceuticals develops novel therapeutics for patients with concussions, aiming to provide effective treatment options beyond rest. The company is conducting Phase 2 human clinical studies for its therapeutic drug, OXE-103, to treat concussions, and is dedicated to advancing brain injury research and treatment. Additionally, Oxeia is actively involved in research related to traumatic brain injuries (TBI), including those caused by military service, sports, falls, and other accidents. The company emphasizes the importance of treatment development for mTBI, which is recognized as an epidemic with significant long-term health and societal impacts.
Industries
Nr. of Employees
small (1-50)
Oxeia Biopharmaceuticals
361 Newbury Street, Suite 500, Boston, MA 02115
Products
Blood–brain barrier–penetrant synthetic ghrelin therapeutic candidate (lead program)
A synthetic ghrelin-based peptide candidate designed to cross the blood–brain barrier, target hippocampal regions, and address neuro‑metabolic dysfunction and axonal injury following concussion; advanced into Phase II clinical studies with reported symptomatic and quality-of-life outcomes in pilot data.
Blood–brain barrier–penetrant synthetic ghrelin therapeutic candidate (lead program)
A synthetic ghrelin-based peptide candidate designed to cross the blood–brain barrier, target hippocampal regions, and address neuro‑metabolic dysfunction and axonal injury following concussion; advanced into Phase II clinical studies with reported symptomatic and quality-of-life outcomes in pilot data.
Services
Design and conduct of multi-site Phase II clinical studies evaluating BBB-penetrant neuroprotective peptide/hormone therapeutics for mild traumatic brain injury, including symptomatic and emergency-room patient cohorts.
Design and conduct of multi-site Phase II clinical studies evaluating BBB-penetrant neuroprotective peptide/hormone therapeutics for mild traumatic brain injury, including symptomatic and emergency-room patient cohorts.
Expertise Areas
- Clinical trial management
- Translational neuroscience
- Neurotrauma therapeutics development
- Regulatory strategy for early-stage investigational drugs
Key Technologies
- Synthetic peptide/hormone therapeutic design
- Blood–brain barrier permeable delivery approaches
- Hippocampus-targeted neuroprotective strategies
- Translational biomarker assessment for neuro‑metabolic dysfunction
News & Updates
Discussion on the importance of improving prevention, diagnosis, and treatment of concussions, especially among seniors and in military veterans.
Research indicating that the cumulative force of head impacts is a key predictor of chronic traumatic encephalopathy (CTE) in athletes.
Data on the high rates of traumatic brain injury (TBI) among veterans and the need for effective treatments.
Discussion on the lack of effective treatments for concussions and the need for research and development of new drugs.
Modern medicine may revolutionize concussion treatment with ongoing Phase 2 trials of OXE103, a synthetic human ghrelin protein, which helps restore normal energy metabolism and stabilize brain function after injury.
Guidance on summer safety precautions to prevent concussions from recreational activities and falls, emphasizing awareness and prompt medical attention.
Discussion on the importance of improving prevention, diagnosis, and treatment of concussions, especially among seniors and in military veterans.
Research indicating that the cumulative force of head impacts is a key predictor of chronic traumatic encephalopathy (CTE) in athletes.
Data on the high rates of traumatic brain injury (TBI) among veterans and the need for effective treatments.
Discussion on the lack of effective treatments for concussions and the need for research and development of new drugs.
Modern medicine may revolutionize concussion treatment with ongoing Phase 2 trials of OXE103, a synthetic human ghrelin protein, which helps restore normal energy metabolism and stabilize brain function after injury.
Guidance on summer safety precautions to prevent concussions from recreational activities and falls, emphasizing awareness and prompt medical attention.